Benchmark Starts Vascular Solutions (VASC) at Buy; Catheter Products are Key
Tweet
Share
E-mailGet Alerts VASC Hot Sheet
Price: $56.00 --0%
Rating Summary:
0 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 6
Rating Summary:
0 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 11 | New: 6
Join SI Premium – FREE
Benchmark initiates coverage on Vascular Solutions (NASDAQ: VASC) with a Buy. PT $15.00.
Analyst, James Terwilliger, said, "In Q1:12, VASC posted Catheter products revenue of $14.9 million. This represented 18% growth compared to the same period last year and represented 63% of total revenue for the quarter. We are encouraged by the strong growth that was visible in Q1:12 as the Pronto aspiration catheter product line faced competitive price pressure. Even with this pressure, the division generated 18% growth and we estimate that if we exclude the Pronto business, which is under pressure, then growth in the Catheter products division would have been in a range of 20-25%...For 2012, we estimate Catheter product revenue of $61.9 million or 63% of total revenue. This represents a 17% growth rate compared to the same period last year. For 2013, we estimate Catheter revenue of $70.5 million."
For an analyst ratings summary and ratings history on Vascular Solutions click here. For more ratings news on Vascular Solutions click here.
Shares of Vascular Solutions closed at $11.87 yesterday.
Analyst, James Terwilliger, said, "In Q1:12, VASC posted Catheter products revenue of $14.9 million. This represented 18% growth compared to the same period last year and represented 63% of total revenue for the quarter. We are encouraged by the strong growth that was visible in Q1:12 as the Pronto aspiration catheter product line faced competitive price pressure. Even with this pressure, the division generated 18% growth and we estimate that if we exclude the Pronto business, which is under pressure, then growth in the Catheter products division would have been in a range of 20-25%...For 2012, we estimate Catheter product revenue of $61.9 million or 63% of total revenue. This represents a 17% growth rate compared to the same period last year. For 2013, we estimate Catheter revenue of $70.5 million."
For an analyst ratings summary and ratings history on Vascular Solutions click here. For more ratings news on Vascular Solutions click here.
Shares of Vascular Solutions closed at $11.87 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intermediate Capital Group (ICP:LN) (ICGUF) PT Raised to GBP22.50 at Citi
- Craig-Hallum Starts Red Robin Gourmet Burgers (RRGB) at Buy
- ASM International NV (ASM:NA) PT Raised to EUR720 at Citi
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
